Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
New treatment more than doubles survival for high risk childhood leukemia
EurekAlert, 10/07/09
Results of a phase two clinical trial show that adding continuous daily doses of a targeted drug called imatinib mesylate to regular chemotherapy more than doubled three–year survival rates for children with a high risk type of blood cancer called Philadelphia chromosome–positive acute lymphoblastic leukemia.
Today in Popular Press...keeping you current
Receive free subspecialty "5-minute updates" via email
How nutrition affects healthy aging
EurekAlert, 12/07/09
Mayo Clinic and collaborators find vitamin D levels associated with survival in lymphoma patients
EurekAlert, 12/07/09
Multiple myeloma patients experience high response rate with new 3-drug combination
EurekAlert, 12/07/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


